log in
Print | Back

Patterson Belknap Webb & Tyler LLP

Jordan M. Engelhardt

Jordan M. Engelhardt



  • Litigation
  • Alternative Dispute Resolution
  • Complex Commercial Actions
  • Biotechnology

WSG Practice Industries



Jordan Engelhardt is Counsel in the Firm's Litigation department, where he represents clients in intellectual property litigation and complex commercial disputes. He has represented pharmaceutical and medical device companies in patent litigation on a wide range of subject matters, and has successfully defended patents protecting blockbuster medical therapies against generic challenges. Mr. Engelhardt’s commercial litigation practice also focuses on disputes relating to structured finance, securities, and corporate governance. He shares the Firm’s commitment to pro bono, with a particular interest in children’s rights. Mr. Engelhardt contributes to the Firm’s Biologics Blog and NY Commercial Division Blog.

Representative Matters

Patent Litigation
Representing a major medical device company in a patent infringement action involving surgical products.

Represented a major pharmaceutical company in ANDA actions involving generic challenges to a first-in-class cancer treatment.

Successfully represented a major pharmaceutical company in Hatch-Waxman litigation involving challenges to eight patents covering a highly successful combination therapy for HIV/AIDS and processes for its manufacture.

Successfully represented an innovator company in multiple ANDA actions involving challenges to patents covering our client's life-saving HIV protease inhibitor.

Structured Finance Litigation
Represented financial guarantors in complex contract and fraud actions against sponsors and underwriters of residential mortgage-backed securities leading to over $1 billion recouped through out-of-court settlements.

Represented a private equity firm pursuing rights and remedies against a mortgage servicer and related entities under transaction documents governing a complex structured finance transaction.

Securities Litigation
Obtained dismissal upheld on appeal of a putative shareholder class action alleging violations of federal securities laws against an officer of a public company.

Corporate Governance
Represented a closely held corporation in defense of a challenge to corporate activities involving a real estate ground lease, including successfully opposing a TRO, resulting in withdrawal of the action.

Represented shareholders of a publicly traded REIT demanding that the board of directors terminate contracts with a mortgage servicer and an asset manager in fulfillment of fiduciary duties.

Conducted an FCPA investigation on behalf of a company with global operations regarding potential payments to foreign officials and conflicts of interest with contractors.

Pro Bono
Representing an asylum applicant who was unlawfully detained and mistreated by police in his home country due to his sexual orientation.

Successfully represented preservationists to prevent removal of historic New York City properties from consideration for landmark protection, leading to designation of multiple new City Landmarks.

Obtained permanent resident status as a Special Immigrant Juvenile for an unaccompanied minor who had suffered abuse and neglect in her home country.

Secured a class action settlement for a class of children in foster care providing substantial reforms to ensure that children do not languish in psychiatric hospitals longer than medically necessary and recovered individual monetary awards for named class representatives.

Represented a defendant-appellant in an appeal to the New York Supreme Court Appellate Term of a misdemeanor criminal conviction.

Bar Admissions

  • U.S. Supreme Court
  • U.S. Court of Appeals, Federal Circuit
  • U.S. District Court, Southern and Eastern Districts of New York
  • New York


  • Cornell Law School (J.D., cum laude, 2009)
    • Cornell Law Review
  • University of Pennsylvania (B.A., summa cum laude, 2006)
Areas of Practice

Alternative Dispute Resolution | Biotechnology | Complex Commercial Actions | Litigation | Patent Litigation

Professional Career

Professional Activities and Experience

MEMBERSHIPS: New York City Bar Association - served on Securities Litigation Committee (Sep. 2015 - Aug. 2018 term)

HONORS: Recipient, Legal Aid Society, Pro Bono Publico Awards (2010-2013, 2017)

SPEAKING ENGAGEMENTS: Presenter, The Legal Aid Society Bronx Juvenile Rights Practice Deposition Training, CLE Event (June 17, 2016); Presenter, “The Financial Reporting and Audit Task Force – The SEC Goes Back to the Future,” New York City Bar CLE Event (April 6, 2016)


FDA Releases Industry Guidance on Development and Licensure of COVID-19 Vaccines
Patterson Belknap Webb & Tyler LLP, July 2020

The Food and Drug Administration (“FDA”) issued its Development and Licensure of Vaccines to Prevent COVID-19: Guidance for Industry on June 30, 2020.  This nonbinding guidance is intended to remain in effect for the duration of the COVID-19 public health emergency declared by the Secretary of Health and Human Services. The guidance advises vaccine development and licensure following the standard trial progression but on an accelerated timeline...

The FDA Regulatory Landscape for COVID-19 Treatments and Vaccines
Patterson Belknap Webb & Tyler LLP, March 2020

As the United States and countries all over the world continue to grapple with the Covid-19 pandemic, the race is on for Covid-19 treatments and vaccines.  There is currently no FDA-approved therapy or vaccine for Covid-19.  Given the profound urgency, life sciences companies and other researchers are prioritizing research and development of potential therapies and vaccines...

Federal Circuit Clarifies Limits of Safe Harbor Defense in Amgen v. Hospira
Patterson Belknap Webb & Tyler LLP, December 2019

Recently, in Amgen Inc. v. Hospira, Inc.,[1] the Federal Circuit clarified the limits of the Safe Harbor defense in cases involving patented manufacturing methods. In a case brought in the District of Delaware, Amgen alleged that Hospira infringed several patent claims over methods of manufacturing erythropoietin (EPO), a biologic drug used to treat anemia...

Additional Articles


New York Commercial Division Decisions
Patterson Belknap Webb & Tyler LLP 

The blog is a source for insights and developments related to practice in the Commercial Division of the New York State Supreme Court. This blog reviews key developments in the Commercial Division, including important decisions handed down by the Commercial Division and appellate court...

WSG's members are independent firms and are not affiliated in the joint practice of professional services. Each member exercises its own individual judgments on all client matters.

HOME | SITE MAP | GLANCE | PRIVACY POLICY | DISCLAIMER |  © World Services Group, 2020